A Randomized, Double-blind, Placebo and Active Comparator Controlled, Parallel Group Thorough QTc Study of Pradigastat in Healthy Male Subjects.

Trial Profile

A Randomized, Double-blind, Placebo and Active Comparator Controlled, Parallel Group Thorough QTc Study of Pradigastat in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Pradigastat (Primary)
  • Indications Hyperlipoproteinaemia type I
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Dec 2016 New trial record
    • 01 Nov 2016 Results published in the Clinical Pharmacology in Drug Development.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top